Isotonische Natriumchlorid-Lösung Eifelfango (Sodium Chloride)

The sodium chloride in the solution dissociates into sodium (Na⁺) and chloride (Cl⁻) ions after administration. These ions increase extracellular osmolarity, drawing water into the vascular space, expanding plasma volume, and restoring osmotic balance. Sodium supports nerve and muscle function, while chloride helps maintain acid‑base equilibrium.

The dose is individualized and set by the prescribing clinician based on the patient’s fluid status, electrolyte needs, route of administration, and clinical condition. No fixed regimen is provided; clinicians calculate volume and rate according to standard fluid‑replacement guidelines.

Safety data in pregnancy and lactation are limited. Because the product is essentially isotonic saline, it is often considered compatible with physiological needs, but prescribers should evaluate the risk‑benefit profile for each patient and monitor maternal and fetal status closely.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and the necessary import documentation.

Isotonische Natriumchlorid-Lösung Eifelfango is comparable to standard 0.9% sodium chloride (normal saline) in composition and osmolarity. It differs mainly in branding, manufacturing origin (EU‑compliant), and packaging. Clinically, it offers the same fluid‑replacement and electrolyte‑balancing properties as other isotonic saline products.

The solution should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect it from direct sunlight, moisture and extreme temperature fluctuations. Do not freeze the product, and inspect the vial for any particulate matter before use.

It is administered by a sterile injection technique via the intramuscular, intravenous or subcutaneous route, according to the clinical indication. The vial is typically withdrawn with a sterile syringe and infused slowly to avoid rapid shifts in plasma volume, following standard aseptic procedures.

Serious risks include severe hypernatremia, fluid overload that can lead to pulmonary edema, and allergic reactions such as anaphylaxis. Patients should be monitored for signs of electrolyte imbalance, respiratory distress, or hypersensitivity during and after infusion.

The solution should be avoided in individuals with known hypersensitivity to sodium chloride, uncontrolled hypertension, severe congestive heart failure, or conditions predisposing to fluid overload. Caution is also advised for patients with renal impairment or those receiving concurrent hypertonic saline solutions.